The heterogeneous expression patterns of serum tumor markers in non-small cell lung cancer patients are predictive factors for progression-free survival
NSCLC patients with a pattern of tumor markers mismatched to their pathological type had unfavourable PFS, suggesting a potentially higher degree of tumor heterogeneity.
Authors
- Zihang Zeng (ORCID: https://orcid.org/0000-0003-1900-8478)
- Zixi Hong
- Siqi Li (ORCID: https://orcid.org/0000-0002-9401-378X)
- Jiali Li (ORCID: https://orcid.org/0009-0006-3550-5473)
- Conghua Xie
Institutions
- Wuhan University (CN)
- Zhongnan Hospital of Wuhan University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-06-16
- DOI
- https://doi.org/10.1007/s12672-025-02969-3
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Wuhan University
- Zhongnan Hospital of Wuhan University